LONDON, Oct. 20, 2022 /PRNewswire/ A world's first model for mood disorders involving precision medicine and mitochondrial treatment with High Dose Levothyroxine and rTMS (patent application
/PRNewswire/ A world s first model for mood disorders involving precision medicine and mitochondrial treatment with High Dose Levothyroxine and rTMS (patent.